Company overview
- Sector
- Pharmaceuticals, Healthcare & Life Sciences
- Sub-sector
- Pharmaceuticals
- Mandate (derived)
- Multi-Function / Full-Stack GCC
- Parent headquarters
- Raleigh, North Carolina, United States
- Parent revenue (USD)
- $2,700,000,000
- Parent headcount
- 7,346
- India headcount
- Not disclosed
GCC locations
- Hyderabad
- Bengaluru
Department mix
Global department counts, used as a proxy for the India mandate. These are not India team counts.
Technology stack
- .GIS
- .NET
- 3XChange
- ACL
- ADP
- AI
- ANGEL LMS
- API Gateway
- ARGUS Developer
- AVEVA PDMS
- AWS Step Functions
- Absorb LMS
- Acquia DAM (Widen)
- Act!
- ActiveProspect
Public leadership
Julian Marina
EA to President & India Country Head and Manager Admin Support & Special Projects
Public leadership listed in the dataset; the role is not necessarily the India GCC head.
Research overview
Parexel International is a global clinical research organization (CRO) providing biopharmaceutical, clinical trial, regulatory affairs and consulting services across ~50+ countries. Headquartered in Newton, Massachusetts, taken private in an $8.5 billion acquisition by EQT Private Equity and Goldman Sachs Asset Management, announced July 2, 2021.
- India launch
- 2007
- Maturity
- Mature / Scaled Multi-Function Hub
Parexel's India operation is ~19 years old (est. 2007), spans multiple cities, and per the India Country Head represents roughly a quarter of Parexel's entire global workforce (5,400+, described as the company's largest single country operation), running clinical operations, biometrics, data management, patient safety, HEOR and IT under dedicated EVP-level in-country leadership.
Location rationale
Company leadership described Hyderabad, at the time India's 6th-largest metropolis, as 'quickly becoming an important biotechnology hub,' with the 2007 office opening framed as a natural extension of Parexel's earlier joint venture with Synchron. No public rationale found for the Bengaluru location.
Timeline
- 2007-06-19
Parexel opens a Hyderabad office, its first dedicated India location, following an earlier joint venture with India-based CRO Synchron.
- 2016-01
Sanjay Vyas joins Parexel; later becomes EVP, Safety & Logistics and Country Head of Parexel India, overseeing what the company describes as its largest single-country operation.
- 2024-10-17
Parexel hosts its 'India Symposium' in Hyderabad (ITC Kohenur), an industry gathering on clinical trial innovation.
Leadership context
The on-file head (Julian Marina) is confirmed to be an Executive Assistant / admin-support role, not the actual India Country Head. The actual India Country Head appears to be Sanjay Vyas (EVP, Safety & Logistics and Country Head of Parexel India), who joined Parexel in January 2016 and per his company profile oversees Parexel India as its largest single-country operation with 5,400+ employees (~25% of Parexel's global workforce). Note: title varies slightly across Parexel-owned sources.
Hiring signal
- Open roles
- 42
- As of
- 2026-08-26
- FSP Program Leader, Data Management
- Senior Health Economics Associate
- Associate, Clinical Outcomes Assessment
- Statistical Programmer II (SDTM)
- Clinical Data Analyst II
News and developments
Parexel India Symposium - Hyderabad 2024
Industry symposium on clinical trial innovation hosted by India leadership with panelists from Hetero, Apollo Hospitals, Alkem Laboratories and CuraTeQ Biologics.
2024-10-17 Parexel.com Events ↗
Sources
Sources and research notes
Source: Indian GCC 2026 Master Compendium, Company Master and research records. Sector, mandate and public leadership are derived fields. Missing values are shown as not disclosed. Revenue and global headcount describe the parent company, not the India centre.